(Q41126310)

27 September 2017

title

Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer (English)

1 reference

27 September 2017

Bradley Downs

1

1 reference

27 September 2017

Yeong C Kim

2

1 reference

27 September 2017

Fengxia Xiao

3

1 reference

27 September 2017

Carrie Snyder

4

1 reference

27 September 2017

Peixian Chen

5

1 reference

27 September 2017

Elizabeth A Fleissner

6

1 reference

27 September 2017

Dina Becirovic

7

1 reference

27 September 2017

Hongxiu Wen

8

1 reference

27 September 2017

Simon Sherman

9

1 reference

27 September 2017

Kenneth H Cowan

10

1 reference

27 September 2017

Henry T Lynch

11

1 reference

27 September 2017

San Ming Wang

12

1 reference

27 September 2017

language of work or name

English

0 references

publication date

2 April 2015

1 reference

Breast Cancer Research and Treatment

27 September 2017

published in

1 reference

27 September 2017

volume

151

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

219-224

1 reference

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Association of common PALB2 polymorphisms with breast cancer risk: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Breast-cancer risk in families with mutations in PALB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Genome instability in blood cells of a BRCA1+ breast cancer family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Fast gapped-read alignment with Bowtie 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

An integrated map of genetic variation from 1,092 human genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

SIFT web server: predicting effects of amino acid substitutions on proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

A method and server for predicting damaging missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

In search of low-frequency and rare variants affecting complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Rare mutations in XRCC2 increase the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Exome sequencing generates high quality data in non-target regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3358-7

10.1007/S10549-015-3358-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 September 2017

1017283943

0 references

1 reference